Roka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE Bioscience
WARREN, N.J., July 10, 2017 /PRNewswire/ — Roka Bioscience, Inc. (“Roka”) (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that it has entered into a two year nonexclusive supply agreement with PURE Bioscience (“PURE”) to market PURE’s line of antimicrobial disinfecting and sanitizing processing aids to the food industry.
The agreement with PURE Bioscience expands Roka Bioscience’s reach into the operational environments of food production with environmental and surface disinfectants and processing interventions for pathogen control, complementing the Atlas system for foodborne pathogen testing.
“Roka Bioscience continues to deliver technology forward solutions to the food industry. With the addition of the PURE Bioscience product line, Roka’s commitment to food safety now extends from the processing floor to the laboratory. We believe that this partnership and our solution approach offer the industry increased control and resolution in pathogen detection and prevention,” stated Mary Duseau, CEO of Roka Bioscience.
Hank Lambert, CEO of PURE said, “We are very excited to partner with Roka in offering advanced science in both pathogen detection and elimination to the food industry. Our proven silver dihydrogen citrate based antimicrobial solutions have been adopted by Chipotle, Taylor Farms, Subway and numerous other food companies for effective pathogen reduction. Partnering with Roka will enable us to extend our solutions to their broad customer portfolio.”
About PURE Bioscience, Inc.
PURE Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena — providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and it mitigates bacterial resistance. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.
About Roka Bioscience:
Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas® Detection Assays incorporate our advanced molecular technologies and are performed on our “sample-in, result-out” Atlas® System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas® System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. For more information, visit http://rokabio.com.
Investor Contact:
Roka Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)
SOURCE Roka Bioscience, Inc.